Alain is an MD trained in Oncology and Hematology. He founded, in 2020, with Grace Yeh and Armand de Gramont, Onward Therapeutics SA, bringing over 35 years of experience in clinical development, management of business units and companies dedicated to Oncology.
Since 2009, Alain has been working as Senior Consultant in Oncology. Prior to this, he held at Sanofi (1998-2009) the positions of Head of the Global Oncology Franchise and Vice President Global Oncology Business Strategy and Development. He also served as Chairman of Chiron Therapeutics Europe and Vice President of Chiron (1991-1998), Managing Director Pierre Fabre Oncologie (1987-1991) and Head of Oncology clinical development at Roger Bellon (1985-1987).
Alain is the President of Onward Therapeutics France and is part of various boards, among others: Nanobiotix, ErVaccine, EMERCell, IDDI, PDC’line, Isofol, Gustave Roussy-Transfert and ARCAD Foundation.